Practice
Mycoplasma genitalium infection
Ameeta E. Singh, Annie-Claude Labbé and Ulrick Auguste
CMAJ January 28, 2019 191 (4) E103; DOI: https://doi.org/10.1503/cmaj.180881
Ameeta E. Singh
University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont.
BMBS MScAnnie-Claude Labbé
University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont.
MDUlrick Auguste
University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont.
MD MScIn this issue
Article tools
Mycoplasma genitalium infection
Ameeta E. Singh, Annie-Claude Labbé, Ulrick Auguste
CMAJ Jan 2019, 191 (4) E103; DOI: 10.1503/cmaj.180881
Jump to section
- Article
- Mycoplasma genitalium infection is an emergent, sexually transmitted infection (STI) that causes similar manifestations to gonorrhea and chlamydia
- Mycoplasma genitalium infection is common worldwide
- Routine testing for Mycoplasma genitalium infection is not recommended
- Treatment options for Mycoplasma genitalium infection are limited by antimicrobial resistance
- Sexual partners should be treated with the same therapy as the index case
- Footnotes
- References
- Responses
- Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.